RNAi silencing of CD9 reduced Matrigel invasion of multiple tumor cell types, including PC-3 and 22Rv1 prostate carcinoma, and MDA-MB-231 breast carcinoma cells. The gene discussed is CD9; the disease is prostate carcinoma.